Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An ependymoma which shows conspicuous cellularity without a significant increase in mitotic rate. (Adapted from WHO)
Biomarker and diagnostic research for cellular ependymoma has been reported in the published literature.
1 clinical trial registered. Pipeline includes 1 PHASE3.
7 publications have been identified in PubMed for cellular ependymoma. Research spans Basic Science / Preclinical (71%), Diagnostic / Biomarker (14%), and Case Report / Case Series (14%).
Das S (2026). [PMID: 41553163](https://pubmed.ncbi.nlm.nih.gov/41553163/). *Clinical neuropathology*. [Basic Science / Preclinical]
Zhang J (2026). [PMID: 41882358](https://pubmed.ncbi.nlm.nih.gov/41882358/). *Nature*. [Basic Science / Preclinical]
Jeong D (2026). [PMID: 41813893](https://pubmed.ncbi.nlm.nih.gov/41813893/). *Nature*. [Case Report / Case Series]
Hack K (2026). [PMID: 41273179](https://pubmed.ncbi.nlm.nih.gov/41273179/). *Neuro-oncology*. [Basic Science / Preclinical]
Alturkustani M (2025). [PMID: 41464145](https://pubmed.ncbi.nlm.nih.gov/41464145/). *Diagnostics (Basel, Switzerland)*. [Diagnostic / Biomarker]
Jeong D (2024). [PMID: 41738029](https://pubmed.ncbi.nlm.nih.gov/41738029/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 4:48 PM UTC
Kardian AS (2024). [PMID: 38527429](https://pubmed.ncbi.nlm.nih.gov/38527429/). *Developmental neuroscience*. [Basic Science / Preclinical]